Skip to content

Mindfulness-based Intervention Versus CBT for Social Anxiety Disorder

Comparative Trial of a Mindfulness-based Intervention Versus Cognitive Behavior Therapy for Social Anxiety Disorder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02490189
Enrollment
97
Registered
2015-07-03
Start date
2015-07-25
Completion date
2018-02-21
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Social Anxiety Disorder

Brief summary

To conduct a prospective, randomized trial to compare the efficacy of a group mindfulness-based intervention adapted for social anxiety disorder (MBI-SAD) versus cognitive behavior group therapy (CBGT).

Detailed description

The main aim of this comparative trial is to determine if the MBI-SAD will be noninferior to CBGT in improving core symptoms of social anxiety disorder, depressive symptoms, self, esteem, disability and quality of life. A secondary aim is to examine whether treatment gains are maintained over a 6-month period. Exploratory aims of the study are to: 1) determine if the MBI-SAD enhances self-compassion and mindfulness relative to CBGT; 2) determine if changes in self-compassion and mindfulness mediate the clinical response to the MBI-SAD; and 3) explore moderators of treatment response.

Interventions

BEHAVIORALMindfulness-based Intervention

Twelve week group intervention that includes training in mindfulness meditation, self-compassion and mindful exposure.

Twelve week group intervention that focuses on the interaction between thoughts, feelings, and behaviors.

Sponsors

Ontario Mental Health Foundation
CollaboratorOTHER_GOV
University of Ottawa
CollaboratorOTHER
Hopital Montfort
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* DSM-5 diagnosis of social anxiety disorder (SAD) of at least moderate severity * Montgomery Asberg Depression Rating Scale score ≤ 25 * Comorbid depressive disorders, panic disorder, agoraphobia, generalized anxiety disorder, specific phobias, eating disorders are allowed as long as the SAD is primary and predominates the clinical picture.

Exclusion criteria

* Coexisting Axis I disorders excluding those listed in the inclusion criteria * Coexisting medical conditions that can alter the clinical presentation of SAD (e.g. Parkinson's disease) * Lifetime history of bipolar disorder or psychotic symptoms * Substance-related disorders in the last 12 months * Acutely suicidal or history of suicide attempt in the past five years * History of non-suicidal self-injurious behavior in the last 12 months * Currently receiving psychotherapy * Currently engaged in a regular meditation or yoga practice * Unable to attend weekly group sessions

Design outcomes

Primary

MeasureTime frameDescription
Liebowitz Social Anxiety ScaleChange from baseline to week 12 and 6-month follow-upA 24-item clinician-rated scale that assesses fear and avoidance of social performance and social situations.

Secondary

MeasureTime frameDescription
Social Phobia InventoryChange from baseline to week 12 and 6-month follow-upA 17-item self-report scale that assesses symptom domains of social anxiety.
Clinical Global Impression Improvement RatingsChange from baseline to week 12 and 6-month follow-upA 7-point clinician-rated scale that assesses level of clinical improvement.
Beck Depression InventoryChange from baseline to week 12 and 6-month-follow-upA 21-item self-report measure of severity of depressive symptoms.
Rosenberg Self-Esteem ScaleChange from baseline to week 12 and 6-month follow-upA 10-item self-report measure of self-esteem.
Satisfaction with Life QuestionnaireChange from baseline to week 12 and 6-month follow-upA 5-item self-report scale that assesses overall satisfaction with life.
Social Adjustment Scale-Self Report RevisedChange from baseline to week 12 and 6-month follow-upA 49-item self-report scale that assesses functional impairment in multiple roles.

Other

MeasureTime frameDescription
Self-Compassion Scale-Short FormChange from baseline to week 12 and 6-month follow-upA 12-item self-report scale that captures how respondents perceive their actions towards themselves in difficult times.
Five-Facet Mindfulness QuestionnaireChange from baseline to week 12 and 6-month follow-upA 39-item self-report inventory that assesses different facets of mindfulness.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026